News
So far this year, just 16 funded U.S. startups in the biotech, drug discovery and medical device spaces have made their ...
More than 100 companies have gone public this year, with Circle and CoreWeave delivering standout performances. As key lockup ...
His own co-host, New York University business school professor and entrepreneur Scott Galloway, who's 60, invested $800,000 ...
The hottest tech stocks are only trading behind closed doors. Gen Z wants in.
Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP ...
Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO market gathers momentum and outrides tariff worries.
UnitedHealth will divest 164 healthcare locations and Amedisys will pay a $1.1 million penalty under a DOJ settlement ...
We're spotlighting headwinds for higher education in this week's coverage from The National Observer, along with Figma's ...
Shoulder Innovations went public at $15 a share, well below its IPO target range, as the medtech firm raised $75 million on the NYSE.
Figma Inc. surged more than 250% on its first day of trading Thursday, marking one of the most explosive public debuts in ...
Fenwick & West received shares in Figma Inc. valued at almost $30 million as the law firm took the lead on legal issues related to the design and collaboration company’s initial public offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results